Shukra Pharmaceuticals Declares Q1 FY27 Results

Shukra Pharmaceuticals Ltd announced its Un-Audited Financial Results for the First Quarter ended June 30, 2026. The company reported a Net Profit of ₹1,502.98 Lakhs for the quarter, a significant increase compared to the previous periods. Total Income from Operations stood at ₹2,406.20 Lakhs. The Board of Directors approved these results, which have been reviewed by the Audit Committee and audited by M/s Shah Sanghvi and Associates. The company also confirmed no investor complaints were received during the quarter.